G-III Apparel (GIII) Beats Consensus

New Post Public Reply Private Reply Replies (0) Message Board
riddock57
Shares of G-III Apparel Group, Ltd. (GIII) surged to reach a new 52-week high in after-hours trading Tuesday as the company delivered quarterly profit and revenue above Wall Street analysts' expectations.

For its first quarter fiscal 2016, GIII posted net sales of $433.0 million, an 18% increase year over year, and net income of $6.8 million, or $0.15 per diluted share, compared to net income of $1.3 million, or $0.03 per diluted share in the same quarter the prior year, topping the Capital IQ Consensus Estimate of $0.07 earnings per share on revenues of $405.76 million for the period.

The company has raised its guidance for the full year fiscal 2016. GIII now expects net sales of approximately $2.40 billion and net income to be in a range of $2.66 to $2.76 per diluted share, compared to its previous guidance of net sales of approximately $2.37 billion and net income between $2.53 and $2.63 per diluted share

GIII designs, manufactures, and markets women's and men's apparel. Its products include outerwear, dresses, sportswear, swimwear, women's suits, and women's performance wear.

More about G-III Apparel Group, Ltd. (GIII) at www.g-iii.com

**

After the closing bell on Tuesday, Ambarella, Inc. (AMBA) reported stronger-than-expected quarterly financial results.

For its first quarter fiscal 2016, AMBA posted revenue of $71.0 million, a 73.5% increase year over year, and non-GAAP net income of $23.7 million, or $0.71 per diluted ordinary share, compared to non-GAAP net income of $7.8 million, or $0.25 per diluted ordinary share in the same quarter the prior year, exceeding the Capital IQ Consensus Estimate of $0.58 earnings per share on revenues of $67.1 million for the period

AMBA said that in addition to continued growth from its existing wearable, IP security and automotive video recorder camera markets, the company sees increased activity across a wide range of home monitoring cameras including models by U.S. service providers, as well as from quadcopters or flying cameras.

AMBA is a leading developer of low-power, high-definition (HD) and Ultra HD video compression and image processing solutions.

More about Ambarella, Inc. (AMBA) at www.ambarella.com

**

On May 29, June 1 and June 2, 2015, Kevin C. Tang, Chairman of Heron Therapeutics, Inc. (HRTX) purchased a total of 150,000 shares of the company in a price range of $19.30 to $23.84, according to a regulatory filing ( FORM 4 ) with the Securities and Exchange Commission (SEC).

Last week, HRTX reported positive, top-line results from its recently completed Phase 3 MAGIC study evaluating the efficacy and safety of its 5-HT3 receptor antagonist product candidate SUSTOL (granisetron injection, extended release), as part of a three-drug regimen for the prevention of delayed-onset chemotherapy-induced nausea and vomiting following administration of highly emetogenic chemotherapy agents.

HRTX is a biotechnology company using its proprietary technology and innovative efforts to develop products to address unmet medical needs.

More about Heron Therapeutics, Inc. (HRTX) at www.herontx.com

**

Crown Equity Holdings Inc. (CRWE) is currently developing its CRWE PR Network, which disseminates community, state, national and global news & information and is also the portal in promoting the company's services, such as its business directory, business-to-business global trading, real estate, press release and video distribution, discounted vouchers and advertising platforms

CRWE's growing network of community targeted sites is expected to be a one-stop shop for the various needs of consumers.

Curbiz ( www.curbiz.com ), in development stage, is an online business directory connecting people with local, state, country and global businesses. Curbiz will provide local advertising services, including free and paid business listing services to businesses of various sizes, as well as enable businesses to deliver targeted search advertising to large local audiences through its Website network and partnership with CRWE PR.

CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com

**

Disclaimer: CRWE-PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE-PR Finance www.finance.crwe-pr.com/disclaimer

G-III Apparel Group (GIII) Stock Research Links

GIII Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading